- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 1/113 - General processes for the preparation of peptides by chemical modification of precursor peptides without change of the primary structure
Patent holdings for IPC class C07K 1/113
Total number of patents in this class: 585
10-year publication summary
|
47
|
57
|
37
|
40
|
35
|
53
|
45
|
39
|
45
|
18
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4242 |
30 |
| President and Fellows of Harvard College | 5964 |
18 |
| The Regents of the University of California | 19857 |
17 |
| Bristol-myers Squibb Company | 4879 |
11 |
| Amgen Inc. | 4071 |
10 |
| Genentech, Inc. | 3979 |
8 |
| Aileron Therapeutics, Inc. | 80 |
8 |
| ImmunoGen, Inc. | 399 |
8 |
| Ajinomoto Co., Inc. | 2304 |
7 |
| Chugai Seiyaku Kabushiki Kaisha | 1348 |
7 |
| The Feinstein Institute for Medical Research | 252 |
7 |
| Genzyme Corporation | 1242 |
7 |
| The Trustees of the University of Pennsylvania | 4314 |
6 |
| The Scripps Research Institute | 1347 |
6 |
| University of Washington | 2317 |
6 |
| Biogen MA Inc. | 893 |
5 |
| Onkure, Inc. | 26 |
5 |
| SeaGen Inc | 586 |
5 |
| Novartis AG | 10886 |
4 |
| Barofold, Inc. | 12 |
4 |
| Other owners | 406 |